McCartney A, Bonechi M, De Luca F, Biagioni C, et al. Plasma thymidine kinase activity as a biomarker in patients with luminal metastatic breast cancer treated with palbociclib within the TREnd trial. Clin Cancer Res 2020 Jan 14. pii: 1078-0432.CCR-19-3271.
PMID: 31937617